NCT00392665 2017-04-13Bevacizumab/Tarceva and Tarceva/Sulindac in Squamous Cell Carcinoma of the Head and NeckMassachusetts General HospitalPhase 2 Terminated36 enrolled 10 charts
NCT01856322 2015-10-23Surgery Plus Sulindac or Surgery Alone for Advanced Colorectal CancerNational Institutes of Health Clinical Center (CC)Phase 2 Terminated3 enrolled 5 charts